World Business Report podcast

Wegovy maker, Novo Nordisk, warns of price squeeze

0:00
8:58
Reculer de 15 secondes
Avancer de 15 secondes

The maker of Ozempic says tougher competition from generics in India and China will hit profits this year. Leanna Byrne speaks to its chief financial officer.

Plus, Spain moves closer to banning social media for under-16s.

And the United States renews a trade deal giving 32 African countries duty-free access to its market.

D'autres épisodes de "World Business Report"